Table 2 Denominator validation results for coverage of injectable antibiotics, women’s exit interview survey, EN-BIRTH study (n = 901)
|  | Country | Hospital | Survey Reported Coverage | Don’t Know Response | |
|---|---|---|---|---|---|
N | % (95% CI) | % | |||
Baby admitted in hospital | Bangladesh | Azimpur Tertiary | 103 | 99 (93, 99.8) | 0 |
Kushtia District | 301 | 99 (96.9, 99.0) | 0 | ||
Nepal | Pokhara Regional | 316 | 97.2 (94.6, 98.5) | 0.32 | |
Tanzania | Temeke Regional | 146 | 99.3 (95.2, 99.9) | 0.68 | |
Muhimbili National | 35 | 100 | 0 | ||
All sites pooled | Random effects estimate | 901 | 98.8 (97.8, 99.5) | 0.2 | |
Baby admitted in hospital and had any infection | Bangladesh | Azimpur Tertiary | 103 | 41.7 (32.1, 51.8) | 0 |
Kushtia District | 301 | 75.4 (70.1, 80.1) | 7.64 | ||
Nepal | Pokhara Regional | 316 | 58.8 (53.2, 64.3) | 2.53 | |
Tanzania | Temeke Regional | 146 | 38.3 (30.4, 46.7) | 4.11 | |
Muhimbili National | 35 | 17.1 (6.5, 33.6) | 8.57 | ||
All sites pooled | Random effects estimate | 901 | 47.1 (30.1, 64.5) | 3.45 | |
Baby admitted in hospital and had a presumed severe infection | Bangladesh | Azimpur Tertiary | 103 | 30.1 (21.5, 39.9) | 2.91 |
Kushtia District | 301 | 70.4 (64.9, 75.5) | 11.3 | ||
Nepal | Pokhara Regional | 316 | 17.4 (13.3, 22.0) | 6.33 | |
Tanzania | Temeke Regional | 146 | 26.7 (19.7, 34.6) | 4.79 | |
Muhimbili National | 35 | 11.4 (3.2, 26.7) | 8.57 | ||
All sites pooled | Random effects estimate | 901 | 30.4 (10.0, 55.9) | 6.48 | |